|
2023
|
Invention
|
Methods and compositions for enhancement of tumor immunogenicity and stimulating anti-tumor immun... |
|
2021
|
Invention
|
Hematopoietic growth factor proteins and analogs thereof and angiotensin converting enzyme inhibi... |
|
|
Invention
|
Methods and compositions for enhancement of stem cell-based immunomodulation and tissue repair.
... |
|
2019
|
Invention
|
Long acting proteins and peptides and methods of making and using the same.
Disclosed is a metho... |
|
|
Invention
|
Cysteine variants of interleukin-11 and methods of use thereof.
Disclosed are cysteine variants ... |
|
2018
|
Invention
|
Methods and use of growth hormone supergene family protein analogs for treatment of radiation exp... |
|
2017
|
Invention
|
Cysteine analogs of exendin-4. Disclosed is a method for refolding a protein or peptide that does... |
|
|
Invention
|
Method to increase the number of circulating platelets by administering pegylated cysteine varian... |
|
|
Invention
|
Methods for making proteins containing free cysteine residues.
The present invention relates to ... |
|
2014
|
Invention
|
Methods of preparing cysteine variants of human recombinant il-11. Disclosed are cysteine variant... |
|
2013
|
Invention
|
Nh2-terminal glutamine modified cysteine variants of interferon gamma. Disclosed is a method for ... |
|
|
Invention
|
Derivatives of growth hormone and related proteins.
The growth hormone supergene family comprise... |
|
|
Invention
|
Method of treatment using cysteine mutants of beta interferon. The growth hormone supergene famil... |
|
2012
|
Invention
|
Methods for making proteins containing free cysteine residues. The present invention relates to n... |
|
|
Invention
|
Methods of treatment using cysteine variants of interleukin-11. Disclosed are cysteine variants o... |
|
2011
|
Invention
|
Methods of use for cysteine variants of human g-csf. The growth hormone supergene family comprise... |
|
|
Invention
|
Cysteine variants of interferon gamma. The growth hormone supergene family comprises greater than... |
|
2010
|
Invention
|
Method for preparing recombinant granulocyte colony stimulating factor cysteine muteins. The pres... |
|
|
Invention
|
Method of preparing cysteine mutants of human recombinant gm-csf. The growth hormone supergene fa... |
|
|
Invention
|
Immunoglobulin fusion proteins.
The present invention relates to novel methods for making fusion... |
|
2009
|
Invention
|
Methods of use of g-csf cysteine muteins. The present invention relates to therapeutic methods fo... |
|
|
Invention
|
In vivo stimulation of peripheral blood progenitor cells by granulocyte-macrophage colony stimula... |
|
|
Invention
|
Cysteine variants of interleukin-11. Disclosed are cysteine variants of interleukin-11 (IL-11) an... |
|
2007
|
Invention
|
Methods of making proteins and peptides containing a single free cysteine. Disclosed is a method ... |
|
|
Invention
|
Long acting proteins and peptides and methods of making and using the same. Disclosed is a method... |
|
|
Invention
|
Methods for refolding proteins containing free cysteine residues.
The present invention relates ... |
|
|
Invention
|
Cysteine variants of interferon-gamma. The growth hormone supergene family comprises greater than... |
|
|
Invention
|
Derivatives of growth hormone and related proteins, and methods of use thereof.
The growth hormo... |
|
2006
|
Invention
|
Method of treatment of an infection in an animal with gm-csf cysteine muteins in the proximal reg... |
|
|
Invention
|
Cysteine muteins in the c-d loop of human interleukin-11. Disclosed are cysteine variants of inte... |
|
|
Invention
|
Long acting vegf inhibitors and methods of use. Disclosed are polymer sFlt-1 conjugates, variants... |
|
2005
|
Invention
|
Enzyme conjugates for use as detoxifying agents.
Disclosed are detoxifying enzyme conjugates, in... |
|
|
Invention
|
Enzyme conjugates for use as detoxifying agents. Disclosed are detoxifying enzyme conjugates, inc... |
|
|
Invention
|
Monopegylated growth hormone proteins. The present invention relates to novel methods of making s... |
|
|
Invention
|
Cysteine substitution variants of beta interferon. The growth hormone supergene family comprises ... |
|
|
Invention
|
Cooh-terminally added cysteine variant of the beta interferon. The growth hormone supergene famil... |
|
2004
|
Invention
|
Cysteine variants of erythropoietin. The growth hormone supergene family comprises greater than 2... |
|
2002
|
Invention
|
Immunoglobulin fusion proteins. The present invention relates to novel methods for making fusion ... |
